Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer
Evolution of nanomedicine is the re-design of synthetic and biological carriers to implement novel theranostic platforms. In recent years, bacteriophage research favors this process, which has opened up new roads in drug and gene delivery studies. By displaying antibodies, peptides, or proteins on t...
Prif Awduron: | Valentina Foglizzo, Serena Marchiò |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
MDPI AG
2021-02-01
|
Cyfres: | Pharmaceuticals |
Pynciau: | |
Mynediad Ar-lein: | https://www.mdpi.com/1424-8247/14/2/161 |
Eitemau Tebyg
-
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
gan: Renato Kaylan Alves França, et al.
Cyhoeddwyd: (2023-09-01) -
Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases
gan: Mohammad Sadraeian, et al.
Cyhoeddwyd: (2024-06-01) -
Native llama Nanobody Library Panning Performed by Phage and Yeast Display Provides Binders Suitable for C-Reactive Protein Detection
gan: Sandra Oloketuyi, et al.
Cyhoeddwyd: (2021-12-01) -
Application of Next Generation Sequencing (NGS) in Phage Displayed Peptide Selection to Support the Identification of Arsenic-Binding Motifs
gan: Robert Braun, et al.
Cyhoeddwyd: (2020-11-01) -
Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5
gan: Jiawen Cao, et al.
Cyhoeddwyd: (2021-02-01)